Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019098
Filing Date
2016-05-11
Accepted
2016-05-11 16:07:29
Documents
61
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q clcd-10q_20160331.htm 10-Q 1165126
2 EX-10.1 clcd-ex101_71.htm EX-10.1 43325
3 EX-31.1 clcd-ex311_12.htm EX-31.1 8056
4 EX-31.2 clcd-ex312_7.htm EX-31.2 8054
5 EX-32.1 clcd-ex321_11.htm EX-32.1 6581
6 EX-32.2 clcd-ex322_8.htm EX-32.2 6579
  Complete submission text file 0001564590-16-019098.txt   5451144

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT clcd-20160331.xml EX-101.INS 1238778
8 XBRL TAXONOMY EXTENSION SCHEMA clcd-20160331.xsd EX-101.SCH 43429
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcd-20160331_cal.xml EX-101.CAL 33154
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcd-20160331_def.xml EX-101.DEF 156048
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcd-20160331_lab.xml EX-101.LAB 349624
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcd-20160331_pre.xml EX-101.PRE 268292
Mailing Address 222 THIRD STREET CAMBRIDGE MA 02142
Business Address 222 THIRD STREET CAMBRIDGE MA 02142 781-365-2596
CoLucid Pharmaceuticals, Inc. (Filer) CIK: 0001348649 (see all company filings)

EIN.: 203419541 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37358 | Film No.: 161639954
SIC: 2834 Pharmaceutical Preparations